Table 2. Univariate and multivariate analyses of average weighted impact score at follow-up.

Variable	Mean±SD	Univariate		Multivariatea
		Coeff.	P value	Coeff.	P valueb
Age, yr		0.030	0.399c	0.043	0.306
Gender		0.572	0.567d
Male	−2.51±1.24			0.016	0.693
Female	−2.48±1.33			Reference
BMI		0.001	0.984c
Waist circumference		0.012	0.772c
SBP		0.051	0.156c
DBP		0.018	0.613c
DM duration, yr		−0.067	0.062c	−0.087	0.044
<5	−2.43±1.29	3.080	0.380e
5–9	−2.42±1.28
10–14	−2.50±1.10
≥15	−2.65±1.41
Comorbidity		−1.485	0.138d
Yes	−2.46±1.26
No	−2.61±1.36
Triglycerides		0.030	0.431c
LDL-C		0.005	0.902c
HDL-C		0.022	0.569c
Total cholesterol		0.001	0.979c
Glucose		−0.093	0.022c
HbA1c		−0.095	0.009c	−0.110	0.012
Insulin therapy		−2.144	0.032d
Yes	−2.68±1.30			−0.016	0.721
No	−2.45±1.28			Reference
Physician behavior change		0.584	0.559d
Yes	−2.45±1.29			0.040	0.326
No	−2.52±1.31			Reference
Patients behavior change		2.501	0.012d
Yes	−2.54±1.28			−0.070	0.085
No	−2.19±1.22			Reference

SD, standard deviation; Coeff., coefficient; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; DM, diabetes mellitus; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin.

^aAdjusted by age and gender, ^bP value by multivariate linear regression, ^cP value by Spearman correlation analysis, ^dP value by Mann-Whitney U test, ^eP value by Kruskal-Wallis test.